EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Weight Regain After Liraglutide, Semaglutide or Tirzepatide Interruption: A Narrative Review of Randomized Studies

Massimo Quarenghi iD, Silvia Capelli iD, Giulia Galligani, Arianna Giana, Giorgia Preatoni, Rosamaria Turri Quarenghi

Journal of Clinical Medicine · 28.05.2025 · 14 (11) · 3791

DOI: 10.3390/jcm14113791 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.05.2025. Verfasst von Massimo Quarenghi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Nutrition and Dietetics, Department of Internal Medicine, Ospedale San Giovanni, Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerl…. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The primary objective of this review is to analyze the effects on body weight of discontinuing therapy with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) or tirzepatide in patients treated for obesity. In recent months, there has been a considerable increase in the utilization of GLP-1 RAs and GIP/GLP-1 RAs. However, the paucity of available data regarding their medium- to long-term safety remains a salient concern. Of particular significance is the observation of the weight curve following their suspension, a subject that has received scant attention to date.

Methods

For this, a bibliographic search was carried out in three electronic databases: PubMed, Cochrane Library and Google Scholar. The following filters were applied: in the last 10 years, Randomized Controlled Trial, Adult: 19+ years. The review was restricted to randomized controlled trials to reduce bias and ensure the high quality of the studies examined. A total of 427 references were identified, 178 articles were read in full, and 13 articles were included in the analysis. Results and Conclusions: The analysis showed a rapid regain of weight after cessation of therapy, regardless of the duration of the treatment with GLP-1 RA or GIP/GLP-1 RA. This rebound is likely to substantially mitigate the metabolic benefits attained through weight loss. Given the efficacy of these drugs, it is essential for future research to focus on elucidating the optimal duration of these treatments or identifying techniques or schemes that involve a reduction in dosages to prevent weight regain.

Schlagwörter

Stichwörter der Autor:innen

GIP/GLP-1 RAbariatric surgeryglucacon like peptide (GLP1 RA)liraglutidesemaglutidetirzepatideweight regain

Autor:innen und Institutionen

  • Clinical Nutrition and Dietetics, Department of Internal Medicine, Ospedale San Giovanni, Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland.
  • Clinical Nutrition and Dietetics, Department of Internal Medicine, Ospedale La Carità, Ente Ospedaliero Cantonale (EOC), 6600 Locarno, Switzerland.
  • Privat Medical Office, 6600 Locarno, Switzerland.

ORCID-Profile: Massimo Quarenghi, Silvia Capelli

Zitieren

APA

Quarenghi, M., Capelli, S., Galligani, G., Giana, A., Preatoni, G., & Turri Quarenghi, R. (2025). Weight Regain After Liraglutide, Semaglutide or Tirzepatide Interruption: A Narrative Review of Randomized Studies. Journal of Clinical Medicine, 14(11), 3791. https://doi.org/10.3390/jcm14113791

Vancouver

Quarenghi M, Capelli S, Galligani G, Giana A, Preatoni G, Turri Quarenghi R. Weight Regain After Liraglutide, Semaglutide or Tirzepatide Interruption: A Narrative Review of Randomized Studies. Journal of Clinical Medicine. 2025;14(11):3791. doi:10.3390/jcm14113791

BibTeX
@article{Quarenghi2025,
  author = {Quarenghi, Massimo and Capelli, Silvia and Galligani, Giulia and Giana, Arianna and Preatoni, Giorgia and Turri Quarenghi, Rosamaria},
  title = {Weight Regain After Liraglutide, Semaglutide or Tirzepatide Interruption: A Narrative Review of Randomized Studies},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {11},
  pages = {3791},
  doi = {10.3390/jcm14113791}
}
Kostenlos starten →